Search Within

Katharine C Hsu

Formats
  1. Journal Article (107)
  2. Meeting Abstract (75)
  3. Research Letter (2)
  4. Book Section (1)
  5. Conference Paper (1)
  6. Review (1)
Groups
  1. Bone Marrow Transplant (187)
  2. Center for Hematologic Malignancies (187)
  3. Department of Medicine (187)
  4. GSK Faculty (187)
  5. Hematologic Malignancies Research (187)
  6. Human Oncology and Pathogenesis Program (187)

More Groups

People
  1. Richard O'Reilly (43)
  2. Bo Dupont (42)
  3. Miguel-Angel Perales (38)
  4. Ann Jakubowski (36)
  5. James Young (36)
  6. Esperanza Papadopoulos (35)

More People

Years
  1. 2025 (4)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (3)
  5. 2021 (11)
  6. 2020 (9)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (43)
  2. Blood (39)
  3. Blood Advances (10)
  4. Bone Marrow Transplantation (10)
  5. Journal of Immunology (8)
  6. Tissue Antigens (5)

More Publications

Publishers
  1. Elsevier Inc. (52)
  2. American Society of Hematology (49)
  3. Nature Publishing Group (15)
  4. American Association for Cancer Research (9)
  5. The American Association of Immunologists, Inc (8)
  6. Wiley-Blackwell Publishing, Inc. (5)

More Publishers

Results (187)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lack of predictive value of KIR-HLA genotypes for autologous transplant outcome for multiple myeloma
    Meeting Abstract

    Hsu, K. C.; Tricot, G.; Haessler, J.; Pinto-Agnello, C.; Van Rhee, F.; Fox, M.; Dupont, B.
    Blood (2006)

    Fulltext@MSK | Save
  • KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy
    Journal Article

    Hsu, K. C.; Gooley, T.; Malkki, M.; Pinto-Agnello, C.; Dupont, B.; Bignon, J. D.; Bornhauser, M.; Christiansen, F.; Gratwohl, A.; Morishima, Y.; more...
    Biology of Blood and Marrow Transplantation (2006)

    Fulltext@MSK | Save
  • Killer immunoglobulin-like receptor ligand (KIR-L) mismatched natural killer (NK) cells for relapsed myeloma
    Meeting Abstract

    Van Rhee, F.; Shi, J.; Szmania, S.; Rosen, N.; Moreno, A.; Walker, R.; Dupont, B.; Hsu, K.; Baxter-Lowe, L. A.; Campana, D.; more...
    Journal of Immunotherapy (2005)

    Fulltext@MSK | Save
  • Killer immunoglobulin-like receptor ligand (KIR-lig) mismatched natural killer (NK) cell transfusions for multiple myeloma (MM)
    Meeting Abstract

    Shi, J.; Szmania, S.; Rosen, N.; Moreno, A.; Walker, R.; Dupont, B.; Hsu, K.; Baxter-Lowe, L. A.; Shaughnessy, J.; Barlogie, B.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Results of T cell depleted (TCD) myeloablative hematopoietic stem cell transplants (HSCT) in patients with hematologic malignancies >= 55 yrs of age
    Meeting Abstract

    Jakubowski, A. A.; Papadopoulos, E. B.; Castro-Malaspina, H. R.; Hsu, K.; Perales, M. A.; Van Den Brink, M.; Young, J. W.; O'Reilly, R. J.
    Blood (2005)

    Fulltext@MSK | Save
  • Missing killer immunoglobulin-like receptor (KIR) ligand confers protection from relapse in recipients of unrelated hematopoietic cell transplantation (HCT) for AML
    Meeting Abstract

    Hsu, K. C.; Malkki, M.; Gooley, T. A.; Dupont, B.; Petersdorf, E. W.
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Lack of HLA-C group 2 KIR ligand in the recipient predictive of lower relapse and higher overall survival in unrelated transplants
    Meeting Abstract

    Hsu, K. C.; Malkki, M.; Gooley, T.; Pinto-Agnello, C.; Dupont, B.; Petersdorf, E.
    Tissue Antigens (2005)

    Fulltext@MSK | Save
  • Fludarabine-based conditioning secures engraftment of secondary hematopoietic stem cell allografts (HSCT) used to treat graft failure
    Meeting Abstract

    Chewning, J. H.; Castro-Malaspina, H. R.; Hsu, K.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; more...
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Induction of remission prior to transplantation improves the disease-free survival (DFS) of patients with advanced myelodysplastic syndromes (MDS) treated with myeloablative T-cell depleted (TCD) stem cell transplants (SCT) from HLA identical siblings
    Meeting Abstract

    Castro-Malaspina, H. R.; Jakubowski, A. A.; Papadopoulos, E. B.; Boulad, F.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Hsu, K. C.; Chiu, M.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation
    Conference Paper

    Kesh, S.; Mensah, N. Y.; Peterlongo, P.; Jaffe, D.; Hsu, K.; Van Den Brink, M.; O'reilly, R.; Pamer, E.; Satagopan, J.; Papanicolaou, G. A.
    John Wiley & Sons (2005)

    Fulltext@MSK | Save